Definitive Contract 75N93023C00057
- Not listed
- This is a Phase II Small Business Innovation Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business headquartered in Monrovia, California. The award, valued at $1,499,763.00, is for the development of a CRISPR-based assay for portable tropical infection diagnosis (CAPTIN-D). This is a Firm Fixed Price definitive contract with a completion date of September 14, 2028. The award is...
- This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,993 Small Business Innovation Research (SBIR) Phase I contract to Chromologic LLC, a minority-owned and Asian-Indian American-owned limited liability company, for the development of "Mobile Health Point-of-Care Diagnostics for Malaria." This contract is focused on research and development of rapid diagnostic technologies for malaria, a...
- Chromologic LLC, a minority-owned small business, has been awarded a definitive fixed-price contract valued at $1,498,121 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of mobile health point-of-care diagnostics for malaria, to be performed in Monrovia, California, with work expected to be completed by January 2025. No set-aside designation was used for this award. Through...
- This is a U.S. government contract awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Small Business Innovation Research (SBIR) Phase I project. The contract, valued at $167,497.00, is a firm fixed-price purchase order set aside for small businesses. The contract supports research and development activities in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures, leveraging Chromologic's expertise in biomedical engineering,...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Chromologic LLC, doing business as Chromologic, a minority-owned small business. The $299,980.00 Firm Fixed Price contract is for the development of a "Highly-Efficient Isolation and Fidelity Differentiation of Exosomes (HIFIDE) from Bodily Fluids Kit" under the Small Business Innovation Research (SBIR) program. Chromologic has...
- The U.S. government has awarded a Small Business Innovation Research (SBIR) Phase II contract worth $846,741.00 to Chromologic LLC, a minority-owned, for-profit limited liability company, to develop the "Microorganisms Genome Enrichment and Amplification Sequencing (MGEAS)" technology. This Firm Fixed Price contract was awarded by the Shared Services Center, a civilian agency, with a completion date of June 13, 2026. Chromologic is a manufacturer of goods and has a strong track...
- This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled "In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures". The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business, for the development of a "Point-of-Care Biological Assay for Determining Tissue-Specific Absorbed Ionizing Radiation Dose (Biodosimeter) After Radiological and Nuclear Events." The contract has a ceiling value of $7,894,687.12 and an ultimate completion date of February 28, 2023. The...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $299,937 firm fixed-price contract to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Phase I Small Business Innovation Research (SBIR) project titled "CHROMOLOGIC." The contract supports research and development efforts for a "CRIPR-BASED ASSAY FOR PORTABLE TROPICAL INFECTION DIAGNOSIS (CAPTIN-D)." There is no set-aside designation for this contract. Chromologic has a track record of securing federal contracts and grants, particularly through SBIR and Small Business Technology Transfer (STTR) programs, across multiple scientific domains including biomedical engineering, molecular biology, and advanced materials science. This contract award is part of a larger SBIR solicitation released by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to stimulate technological innovation and strengthen the role of small businesses in meeting federal research needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/14/23 | |
| Not listed | Not listed | $299.9k | 9/12/23 |